Rmb Capital Management, LLC Abbott Laboratories Transaction History

Rmb Capital Management, LLC

$4.3 Billion
Q3 2024

A detailed history of Rmb Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rmb Capital Management, LLC holds 88,964 shares of ABT stock, worth $10.2 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

88,964

Previous 98,193 9.4%

Holding current value

$10.2 Million

Previous $10.2 Million 0.6%

% of portfolio

0.24%

Previous 0.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$100.07 - $118.13 $923,546 - $1.09 Million	-9,229 Reduced 9.4%	88,964 $10.1 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $2.55 Million - $2.84 Million	-25,299 Reduced 20.49%	98,193 $10.2 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $6.25 Million - $6.9 Million	57,039 Added 85.83%	123,492 $14 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $34,182 - $41,841	-379 Reduced 0.57%	66,453 $7.31 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $19,679 - $23,611	-206 Reduced 0.31%	66,832 $6.47 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $120,230 - $133,961	-1,193 Reduced 1.75%	67,038 $7.31 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $3,486 - $4,104	-36 Reduced 0.05%	68,231 $6.91 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $479,387 - $562,395	5,043 Added 7.98%	68,267 $7.5 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $575,334 - $666,130	-5,946 Reduced 8.6%	63,224 $6.12 Million
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $293,145 - $354,318	2,872 Added 4.33%	69,170 $7.52 Million
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $84,260 - $102,750	-739 Reduced 1.1%	66,298 $7.85 Million
Q4 2021 Jan 26, 2022	SELL	$115.53 - $141.46 $504,057 - $617,189	-4,363 Reduced 6.11%	67,037 $9.44 Million
Q3 2021 Oct 20, 2021	BUY	$116.66 - $129.06 $230,053 - $254,506	1,972 Added 2.84%	71,400 $8.43 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $18,936 - $22,290	-179 Reduced 0.26%	69,428 $8.05 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $604,932 - $712,702	-5,558 Reduced 7.39%	69,607 $8.34 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $1.43 Million - $1.56 Million	-13,619 Reduced 15.34%	75,165 $8.23 Million
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $154,688 - $187,857	-1,688 Reduced 1.87%	88,784 $9.66 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $1.4 Million - $1.79 Million	-18,313 Reduced 16.83%	90,472 $8.27 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $918,554 - $1.34 Million	-14,622 Reduced 11.85%	108,785 $8.58 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $52,523 - $58,470	-669 Reduced 0.54%	123,407 $10.7 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $883,953 - $958,480	-10,801 Reduced 8.01%	124,076 $10.4 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $2.07 Million - $2.41 Million	28,394 Added 26.67%	134,877 $11.3 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $453,871 - $548,731	6,854 Added 6.88%	106,483 $8.51 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $166,653 - $188,794	2,542 Added 2.62%	99,629 $7.21 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $164,977 - $199,025	2,713 Added 2.87%	97,087 $7.12 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $27,748 - $30,626	482 Added 0.51%	94,374 $0
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $3.08 Million - $3.49 Million	-54,792 Reduced 36.85%	93,892 $5.63 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $2.55 Million - $2.73 Million	47,489 Added 46.93%	148,684 $8.49 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $536,013 - $598,246	11,153 Added 12.39%	101,195 $5.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	90,042	90,042 $4.38 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Account

Rmb Capital Management, LLC Abbott Laboratories Transaction History